Hyderabad, April 2026: Telangana IT and Industries Minister D. Sridhar Babu has launched advanced diagnostic kits for drug-resistant tuberculosis (TB) at Genome Valley, marking a significant step in strengthening India’s fight against TB.
Boost to Indigenous Healthcare Innovation
The newly launched kits, developed at Hyderabad’s Genome Valley, are part of a broader push to enhance domestic manufacturing of medical technologies. The facility, set up by global diagnostics company bioMérieux, represents a key milestone in India’s growing biotech ecosystem.
Officials said the initiative highlights Telangana’s emergence as a major hub for life sciences and healthcare innovation.
Focus on Early Detection of Drug-Resistant TB
Speaking at the launch, the minister stressed that drug-resistant TB is a serious public health challenge, as it does not respond to conventional treatment. He highlighted that early diagnosis and timely medical intervention are crucial to saving lives and preventing further spread of the disease.
The advanced kits are designed to deliver faster and more accurate detection, helping healthcare providers identify resistance to specific drugs at an early stage.
Investment and Employment Generation
The Genome Valley facility has been established with an initial investment of around ₹50 crore and has already generated employment for about 100 people.
The company has also announced plans to set up a dedicated research and development (R&D) centre, further strengthening innovation capabilities in the region.
Strengthening Global Partnerships
The launch event saw participation from senior representatives of the French government and industry, underlining growing India-France collaboration in the healthcare sector.
Officials noted that such partnerships are crucial for bringing advanced diagnostic technologies and global expertise to India.
Step Towards TB Elimination Goals
With India bearing a significant burden of tuberculosis cases, the introduction of these diagnostic kits is expected to:
- Improve early detection rates
- Enhance treatment outcomes
- Support the country’s goal of eliminating TB
